Successful treatment of IgG4-related disease with tocilizumab monotherapy
Autoimmunity Reviews · 2023
DOI: 10.1016/j.autrev.2023.103296 ↗Kurz gefasst
Leserbrief in der Zeitschrift Autoimmunity Reviews, 2023. Verfasst von Mitsuhiro Akiyama und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, 1608582 Tokyo, Japan; Department of Rheumatology, Japa…. Hauptthemen laut MEDLINE: Immunoglobulin G4-Related Disease, Antirheumatic Agents. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 8 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, 1608582 Tokyo, Japan; Department of Rheumatology, Japanese Red Cross Ashikaga Hospital, Ashikaga, Japan. Electronic address:…
- Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, 1608582 Tokyo, Japan.
Zitieren
APA
Akiyama, M., Hayashi, Y., Suzuki, K., Takeuchi, T., & Kaneko, Y. (2023). Successful treatment of IgG4-related disease with tocilizumab monotherapy. Autoimmunity Reviews. https://doi.org/10.1016/j.autrev.2023.103296
Vancouver
Akiyama M, Hayashi Y, Suzuki K, Takeuchi T, Kaneko Y. Successful treatment of IgG4-related disease with tocilizumab monotherapy. Autoimmunity Reviews. 2023. doi:10.1016/j.autrev.2023.103296
BibTeX
@article{Akiyama2023,
author = {Akiyama, Mitsuhiro and Hayashi, Yutaro and Suzuki, Koji and Takeuchi, Tsutomu and Kaneko, Yuko},
title = {Successful treatment of IgG4-related disease with tocilizumab monotherapy},
journal = {Autoimmunity Reviews},
year = {2023},
doi = {10.1016/j.autrev.2023.103296}
}
EUVIMED